New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Source: Virtual Congress 2020 – German programme 2020 Year: 2020
The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008
Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases Source: Eur Respir J , 49 (2) 1601855; DOI: 10.1183/13993003.01855-2016 Year: 2017
Clinical relevance of Mycobacterium simiae in pulmonary samples Source: Eur Respir J 2008; 31: 106-109 Year: 2008
Diagnosis, classification and epidemiology of pulmonary nontuberculous mycobacterial disease Source: Eur Respir Monogr 2018; 81: 204-221 Year: 2018
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Guideline 2020 Year: 2020
Silica exposure, silicosis, autoimmune diseases, tuberculosis and nontuberculous pulmonary mycobacterial disease Source: International Congress 2016 – Occupational epidemiology Year: 2016
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020 Year: 2020
Management of pulmonary nontuberculous mycobacteria disease Source: Eur Respir Monogr 2018; 81: 222-237 Year: 2018
Pulmonary diseases due to non-tuberculous mycobacteria in TB referral clinical center Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011
Cases series on nontuberculous mycobacterial (NTM) lung disease and silicosis in Brazil Source: International Congress 2017 – Case reports and series Year: 2017
When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019
The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada Source: Eur Respir J 2011; 37: 1158-1165 Year: 2011
From detection of nontuberculous mycobacteria (NTM) in pulmonary specimens to pulmonary infections Source: Eur Respir J 2004; 24: Suppl. 48, 420s Year: 2004
Perspectives on antibiotic treatment of NTM pulmonary disease Source: Eur Respir Monogr 2017; 75: 245-252 Year: 2017
TB, NTM and bronchiectasis Source: ERS Skills Course 2016 Year: 2016
Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat? Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017 Year: 2017
Burden of non-tuberculous mycobacterial pulmonary disease in Germany Source: Eur Respir J , 49 (4) 1602109; DOI: 10.1183/13993003.02109-2016 Year: 2017
Fungal VAP Source: Eur Respir Mon 2011; 53: 122-137 Year: 2011